CAS number index
Every CAS Registry Number in our catalogue, sorted numerically. Paste a CAS No. into the search bar to jump straight to the product.
| CAS No. | Substance | Grades |
|---|---|---|
| 126849-31-8 | Bromfenac Impurity B (Sodium Salt) | 1 |
| 126849-37-4 | Amfenac keto Impurity | 1 |
| 126856-99-3 | Pirenzepine EP Impurity C | 1 |
| 126857-76-9 | N-9-Acridinyl-2-bromoacetamide | 1 |
| 126860-83-1 | Calcipotriol EP Impurity A | 1 |
| 126910-68-7 | Methyl 5-chloro-3-(chlorosulfonyl)-2-thiophenecarboxylate | 1 |
| 126918-16-9 | (R)-1-(2,4-Difluorophenyl)-2-hydroxypropan-1-one | 1 |
| 126918-17-0 | (2R)-1-(2,4-Difluorophenyl)-2-(tetrahydro-2H-pyran-2-yloxy)propan-1-one | 1 |
| 126918-35-2 | (2R,3R)-3-(2,4-Difluorophenyl)-3,4-Epoxybutan-2-ol | 1 |
| 126939-25-1 | 2-Bromo-4H-benzo[4,5]cyclohepta[1,2-b]thiophen-4-one | 1 |
| 126939-27-3 | Ketotifen EP Impurity C | 1 |
| 126990-35-0 | Dicyclopentyl(dimethoxy)silane, 99%+ | 1 |
| 127000-20-8 | Gadobenate Dimeglumine | 1 |
| 127000-90-2 | 1-(((2R,3S)-2-(2,4-Difluorophenyl)-3-methyloxiran-2-yl)methyl)-1H-1,2,4-triazole | 1 |
| 127001-03-0 | (2S)-1-(2,4-Difluorophenyl)-2-((tetrahydro-2H-pyran-2-yl)oxy)propan-1-one | 1 |
| 127017-69-0 | Paroxetine Hydrochloride Hemihydrate EP Impurity B | 1 |
| 127017-74-7 | Paroxetine Hydrochloride HemiHydrate EP Impurity B | 1 |
| 127034-59-7 | 11,12-Dehydroxy-Betamethasone | 1 |
| 127053-22-9 | Nabumetone EP Impurity D | 1 |
| 127084-74-6 | Tolnaftate EP Impurity B | 1 |
| 127105-40-2 | 9,10-Dihydroxy-12,13-epoxy stearic acid | 1 |
| 127140-69-6 | Clarithromycin EP impurity H | 1 |
| 127157-35-1 | Clarithromycin EP impurity K | 1 |
| 127182-43-8 | Clarithromycin EP impurity M | 1 |
| 127182-44-9 | Clarithromycin EP impurity G | 1 |
| 127205-22-5 | 2-Amino-1,7-dihydro-7-[4-hydroxy-3-(hydroxymethyl)butyl]-6H-purin-6-one | 1 |
| 127252-80-6 | Clarithromycin EP impurity O | 1 |
| 127253-05-8 | Clarithromycin EP Impurity L | 1 |
| 127253-06-9 | Clarithromycin EP impurity C | 1 |
| 127264-14-6 | Darifenacin Impurity B | 1 |
| 127277-53-6 | Prohexadione Calcium, plant tissue culture tested | 1 |
| 127285-26-1 | Tacrolimus Impurity X | 1 |
| 127285-54-5 | 6,7-Dimethoxyquinolin-4(1H)-one | 1 |
| 127293-50-9 | 4-(2,4-Dichlorophenyl)-3,4-dihydronaphthalen-1(2H)-one | 1 |
| 127294-73-9 | (R)-3-Aminopiperidine | 1 |
| 127299-26-7 | Agomelatine Impurity 17 | 1 |
| 127299-95-0 | Digoxin-d3 | 1 |
| 127324-00-9 | 5-Amino-2-iodoisophthalic Acid | 1 |
| 127324-01-0 | 5-Amino-4-iodoisophthalic Acid | 1 |
| 127324-02-1 | 5-Amino-2,4-diiodoisophthalic Acid | 1 |
| 127324-03-2 | 5-Amino-4,6-diiodoisophthalic Acid | 1 |
| 127324-78-1 | Ethane-1,2-diyl bis(4-phenylbutanoate) | 1 |
| 127337-60-4 | Lansoprazole Chloromethyl Impurity | 1 |
| 127369-30-6 | (S)-Methyl 2-amino-2-(4-hydroxyphenyl)acetatehydrochloride | 1 |
| 127406-56-8 | 4-(2-Pyridyl) Benzaldehyde | 1 |
| 127413-31-4 | Flecainide D3 | 1 |
| 127464-43-1 | Emoxypine Succinate | 1 |
| 127468-07-9 | 5-O-Demethyl-22,23-dihydro-28-hydroxy-Avermectin A1a | 1 |
| 127472-42-8 | Granisetron EP Impurity A | 1 |
| 127516-23-8 | 1-β-Hydroxy Vitamin D2 | 1 |
| 127615-60-5 | 3-Nitrotetrazolium blue chloride | 1 |
| 127649-09-6 | Butylated hydroxyl toluene methane sulfonated | 1 |
| 127676-18-0 | Pioglitazone Impurity 6 | 1 |
| 127684-08-6 | 7-Keto Cholesterol-d7 | 1 |
| 127749-26-2 | Cidofovir Sodium Uracil Analog | 1 |
| 127755-21-9 | N-Nitroso N-Desethyl Oxybutynin Impurity (N-1) | 1 |
| 127759-89-1 | Lobucavir | 1 |
| 127770-93-8 | O-Acetyl Cefdinir | 1 |
| 127780-16-9 | Pantoprazole EP Impurity A | 1 |
| 127785-64-2 | Basifungin | 1 |
| 127791-51-9 | 1-Butane sulphonic acid sodium salt monohydrous, for HPLC ≥99.00% | 1 |
| 127792-23-8 | Diclofenac EP Impurity D | 1 |
| 127792-45-4 | Diclofenac EP Impurity D (Sodium Salt) | 1 |
| 127852-28-2 | (AlphaR)-alpha-Methyl-3,5-bis(trifluoromethyl)benzenemethanol | 1 |
| 127865-20-7 | 1-Phenyl-2-(piperidin-1-ylmethyl)prop-2-en-1-one | 1 |
| 127910-58-1 | (S,S)-3-Hydroxy Lovastatin | 1 |
| 127913-44-4 | (3S)-4-Chloro-3-hydroxybutyronitrile | 1 |
| 127946-77-4 | 1-Amino-1-cyclopropanecarbonitrile hydrochloride, 97% | 1 |
| 127955-44-6 | Erythromycin EP Impurity L | 1 |
| 127958-23-0 | (Z)-Methyl2-[(Dimethylamino)methylene]-4-methoxy-3-oxobutanoate | 1 |
| 127984-74-1 | Lanreotide Acetate | 1 |
| 127984-76-3 | Tacrolimus 31 DMT | 1 |
| 127985-74-4 | p-SCN-Bn-DOTA, ≥99% | 1 |
| 128012-77-1 | 2-((((Z)-1-(2-Aminothiazol-4-yl)-2-(((6aR,7R)-1,8-Dioxo-1,3,4,5,6a,7-Hexahydro-8H-azeto[2,1-b]pyrano[3,4-d][1,3]thiazin-7-yl)Amino)-2-Oxoethylidene)Amino)oxy)acetic Acid | 1 |
| 128013-69-4 | rac-Pregabalin | 1 |
| 128018-43-9 | Benzyl | 1 |
| 128036-32-8 | Fluoxetine Impurity 2 Hydrochloride | 1 |
| 128071-98-7 | 2-Fluoro-4-bromo pyridine, 97% | 2 |
| 128107-47-1 | Fmoc-D-Ser(tBu)-OH, ≥98% (TLC) | 1 |
| 128120-08-1 | 2-(4-Butylphenyl) Propanal | 1 |
| 128142-41-6 | 5'-(Hydroxymethyl)-7,7'-dimethoxy-[4,4'-bibenzo[d][1,3]dioxole]-5-carboxylic Acid | 1 |
| 128173-53-5 | Escitalopram USP Related Compound A | 1 |
| 128196-01-0 | Escitalopram Oxalate | 1 |
| 128196-02-1 | Escitalopram Impurity K | 1 |
| 128202-57-3 | (1-Hydroxy-3-(methylamino)propane-1,1-diyl)diphosphonic Acid | 1 |
| 128221-48-7 | Antimony doped tin oxide nanopowder, APS <100 nm 99.9% | 3 |
| 128270-60-0 | Bivalirudin | 1 |
| 128272-36-6 | Methyl 6-(4-methoxyphenyl)-2-naphthoate | 1 |
| 128326-82-9 | Eberconazole | 1 |
| 128366-50-7 | 3-Hydroxy Medetomidine | 1 |
| 128366-51-8 | 3-Carboxy-dexmedetomidine | 1 |
| 128396-56-5 | Benzisothiazole sulphoxide | 1 |
| 128420-71-3 | Minocycline Hydrochloride Dihydrate | 1 |
| 128430-66-0 | Lansoprazole Chloromethyl Impurity (Freebase) | 1 |
| 128438-01-7 | (Z)-2-(2-Aminothiazol-4-yl)-2-((trityloxy)imino)acetic Acid | 1 |
| 128446-32-2 | (2-Hydroxyethyl)-β-cyclodextrin | 1 |
| 128446-34-4 | (2-Hydroxypropyl)-gamma-cyclodextrin | 1 |
| 128446-35-5 | (2-Hydroxypropyl)-ß-Cyclodextrin, for cell culture, 99%+ | 4 |
| 128446-36-6 | Methyl-ß-cyclodextrin, 98%+ | 2 |
| 128486-89-5 | 6-Hydroxy Alosetron | 1 |
| 128517-07-7 | Romidepsin | 1 |
| 128585-02-4 | Ospemifene Metabolite M3 | 1 |
| 128596-80-5 | 3'-Sialyllactose Sodium Salt | 1 |
| 128607-22-7 | Ospemifene | 1 |
| 128625-52-5 | PyBOP, extra pure >98% | 2 |
| 128639-02-1 | Carfentrazone-ethyl | 1 |
| 128740-13-6 | 6-Benzyl-5,7-dioxooctahydropyrrolo[3,4-b]pyridine | 1 |
| 128779-47-5 | Boc-D-4,4-Biphenylalanine | 1 |
| 128779-50-0 | 2-{[(1S,2S)-1-Hydroxy-1-phenylpropan-2-yl](methyl)amino}acetic acid | 1 |
| 128794-94-5 | Mycophenolate Mofetil | 1 |
| 128796-39-4 | 4-(Trifluoromethyl)phenylboronic acid, 95% | 1 |
| 128915-56-0 | N-Desmethyl Asenapine | 1 |
| 128940-83-0 | Clarithromycin EP Impurity F | 1 |
| 128949-51-9 | Asenapine N-Oxide | 1 |
| 128954-45-0 | Formoterol | 1 |
| 128963-10-0 | 2`,3`,5`-tri-O-acetyl-5-fluorocytidine | 1 |
| 129044-45-7 | Demeclocycline EP Impurity C | 1 |
| 129050-23-3 | (2S, 2'S)-6-Fluoro-2-(2′-oxiranyl)chromane | 1 |
| 129050-26-6 | Nebivolol B Isomer | 1 |
| 129083-44-9 | Famotidine EP impurity E | 1 |
| 129101-33-3 | Didefluoro Nebivolol | 1 |
| 129101-34-4 | Defluoro Nebivolol | 1 |
| 129101-35-5 | Nebivolol Impurity 40 (SRSS) | 1 |
| 129101-54-8 | Rivastigmine Tartrate | 1 |
| 129165-82-8 | Mebendazole EP Impurity G | 1 |
| 129212-35-7 | 8-Epitacrolimus | 1 |
| 129212-37-9 | Tacrolimus Dehydro Impurity | 1 |
| 129225-21-4 | Ganirelix Acetate Impurity D | 1 |
| 129225-22-5 | N-Acetyl-3-(2-naphthalenyl)-D-alanyl-4-chloro-D-phenylalanyl-3-(3-pyridinyl)-D-alanine | 1 |
| 129225-23-6 | Ganirelix Impurity 1 | 1 |
| 129244-90-2 | 5-9-Leuprolide | 1 |
| 129254-76-8 | 1-(3-Bromopropyl)-3-(trifluoromethyl) benzene | 1 |
| 129260-79-3 | Loteprednol | 1 |
| 129262-07-3 | (R,R)-Benidipine Hydrochloride | 1 |
| 129262-08-4 | (S,S)-Benidipine Hydrochloride | 1 |
| 129277-08-3 | Ethyl (R)-2-((methylsulfonyl)oxy)-4-phenylbutanoate | 1 |
| 129311-55-3 | Ganirelix Acetate | 1 |
| 129318-43-0 | Alendronic Acid Sodium Salt | 1 |
| 129332-29-2 | tert-Butyl Fluvastatin | 1 |
| 129365-93-1 | 4,5-Diaminophthalonitrile, 95% | 1 |
| 129385-59-7 | Asenapine Impurity 1 | 1 |
| 129385-60-0 | Asenapine Tetradehydro Impurity | 1 |
| 129418-54-8 | Triptorelin Related Compound C | 1 |
| 129453-61-8 | Fulvestrant | 1 |
| 129454-96-2 | (2E,4E,6E)-3-Methyl-7-(5,5,8a-trimethyl-3,5,6,7,8,8a-hexahydrobenzo[c][1,2]dioxin-3-yl)octa-2,4,6-trienoic Acid | 1 |
| 129459-98-9 | Alclometasone-21-propionate | 1 |
| 129460-09-9 | 1-tert-Butyl N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-L-aspartate, 98% | 1 |
| 129482-56-0 | 4,5-Dichloro-4,5-dimethyl-1,3-dioxolan-2-one | 1 |
| 129496-10-2 | Milbemycin Oxime | 1 |
| 129497-78-5 | Verteporfin | 1 |
| 129499-78-1 | Ascorbyl Glucoside | 1 |
| 129511-06-4 | Methyl 4-amino-5-chloro-2-hydroxybenzoate | 1 |
| 129541-41-9 | 5-Bromo-4-chloro-3-indolyl β-D-glucuronide sodium salt, ≥98% | 1 |
| 129558-76-5 | Tolfenpyrad | 1 |
| 129603-01-6 | tert-Butyl (R)-(1-(methoxy(methyl)amino)-4-methyl-1-oxopentan-2-yl)carbamate | 1 |
| 129618-40-2 | Nevirapine | 1 |
| 129622-98-6 | (2Z)-4-[[4-(1-Piperidinylmethyl)-2-pyridinyl]oxy]-2-buten-1-ol | 1 |
| 129700-41-0 | Atovaquone EP Impurity D | 1 |
| 129720-95-2 | Aminolevulinic-13C Acid Hydrochloride | 1 |
| 129722-12-9 | Aripiprazole | 2 |
| 129722-20-9 | Aripiprazole Inhouse Impurity G | 1 |
| 129722-25-4 | Aripiprazole EP Impurity E | 1 |
| 129722-34-5 | Aripiprazole Bromobutoxyquinoline Impurity | 1 |
| 129797-28-0 | (2S,3S,4R,5S)-3,4,5-Trihydroxy-2-piperidinecarboxylic acid | 1 |
| 129799-08-2 | Methyl (±)-4-Boc-piperazine-2-carboxylate, 97% | 1 |
| 129938-20-1 | Dapoxetine Hydrochloride | 1 |
| 129939-63-5 | Ramipril EP Impurity N | 1 |
| 129939-65-7 | Ramipril EP Impurity I | 1 |
| 129951-06-0 | N-Benzyl 4-phenyl Butanamine | 1 |
| 129954-34-3 | Selank | 1 |
| 129970-98-5 | Perindopril Diketopiperazine | 1 |
| 129970-99-6 | Perindopril EP Impurity C | 1 |
| 129973-75-7 | N-Desmethyl Clobazam-d5 | 1 |
| 129973-76-8 | Clobazam-d5 | 1 |
| 130000-40-7 | Thifluzamide | 1 |
| 130004-33-0 | [RuCl(p-cymene)((S)-binap)]Cl, 98% | 1 |
| 130018-76-7 | Levocetirizine Dihydrochloride - Impurity A | 1 |
| 130018-77-8 | Levocetirizine | 2 |
| 130018-87-0 | Levocetirizine dihydrochloride | 1 |
| 130018-89-2 | Cetirizine S-Isomer | 1 |
| 130049-82-0 | Paliperidone USP RC C | 1 |
| 130049-85-3 | (R)-9-Hydroxy Risperidone | 1 |
| 130061-28-8 | Perindopril EP Impurity D | 1 |
| 130063-07-9 | D-Homoanalog Of Triamcinolone | 1 |
| 130100-20-8 | Mag-Fura-2-AM, ≥95% | 1 |
| 130104-32-4 | Eberconazole Nitrate | 1 |
| 130115-63-8 | Pindolol EP Impurity B | 1 |
| 130115-65-0 | Pindolol EP Impurity C | 1 |
| 130115-66-1 | Pindolol EP Impurity F | 1 |
| 130126-89-5 | Eberconazole Hydroxyderivative Impurity | 1 |
| 130144-34-2 | (Rac)-7-Ethyl-10-Hydroxy Camptothecin | 1 |
| 130145-14-1 | 9(11)-Fluorometholone Acetate | 1 |
| 130171-52-7 | 4-Trifluoromethylpyridine-2,6-diamine | 1 |
| 130190-60-2 | 5-Bromo-2-benzoylpyrrole | 1 |
| 130198-05-9 | Venlafaxine EP Impurity C HCL | 1 |
| 130209-76-6 | Bimatoprost Acid Isopropyl Ester | 1 |
| 130209-82-4 | Latanoprost | 2 |
| 130232-51-8 | Ciprofibrate EP Impurity D | 1 |
| 130262-92-9 | 5-Hydroxymethyl 5-Desmethyl Meloxicam | 1 |
| 130262-93-0 | 5'-Carboxy Meloxicam | 1 |
| 130263-14-8 | Emedastine EP Impurity D | 1 |
| 130273-87-9 | Bimatoprost Isopropyl Ester | 1 |
| 130290-79-8 | Tetrahydro-4-Aminomethylpyran | 1 |
| 130308-48-4 | Icatibant, 98% | 1 |
| 130309-33-0 | Fmoc-D-Tic-OH, 98% | 1 |
| 130309-35-2 | Fmoc-β-(2-thienyl)-Ala-OH, 98% | 1 |
| 130309-37-4 | Fmoc-D-Tic-OH, 98% | 1 |
| 130334-60-0 | Des-D-Arg(1)-Icatibant | 1 |
| 130336-16-2 | 2,2,2-Trifluoro-1-(3,5-dichlorophenyl)ethanone, 95% | 1 |
| 130468-09-6 | Cefepime Declatam Lactone Decarboxylate | 1 |
| 130468-11-0 | Simvastatin 6-Oxo Isomer | 1 |
| 130525-62-1 | Zanamivir EP Impurity C | 1 |
| 130536-69-5 | 2-(2-iodoethoxy)ethanol | 1 |
| 130539-72-9 | Nadifloxacin isomer 2 | 1 |
| 130566-58-4 | 2-[4-[2-(1-Piperidinyl)ethoxy]benzoyl]benzoic Acid | 1 |
| 130567-83-8 | Mogroside III | 1 |
| 130579-75-8 | Eplivanserin | 1 |
| 130593-75-8 | Ursodeoxycholic Acid EP Impurity I | 1 |
| 130606-60-9 | Diltiazem EP Impurity D | 1 |
| 130622-05-8 | (R)-Dimethyl 2-((tert-Butoxycarbonyl)amino)pentanedioate | 1 |
| 130642-50-1 | Desloratadine Methanone Impurity | 1 |
| 130642-57-8 | Desloratadine 8-Bromo-N-Methyl Impurity | 1 |
| 130642-60-3 | Loratadine 8-Bromo Impurity | 1 |
| 130668-48-3 | Buprenorphine EP Impurity E | 1 |
| 130676-63-0 | N-Formyl-L-leucine [S-(E)]-1-(2-Nonenyl)dodecyl Ester | 1 |
| 130676-64-1 | Orlistat Dihydropyranone Impurity | 1 |
| 130676-65-2 | N-Formyl-L-leucine (3S,4S,6S)-3-Hexyltetrahydro-2-oxo-6-undecyl-2H-pyran-4-yl Ester | 1 |
| 130676-66-3 | Orlistat Open Ring (2S,3S,5S)-Isomer | 1 |
| 130693-82-2 | Dorzolamide Hydrochloride | 1 |
| 130793-26-9 | Orlistat Impurity 12 | 1 |
| 130793-27-0 | Orlistat USP Related Compound D | 1 |
| 130793-28-1 | Orlistat open ring epimer | 1 |
| 130855-30-0 | ent-Paroxetine Hydrochloride | 1 |
| 130914-71-5 | Valganciclovir EP Impurity F | 1 |
| 130914-77-1 | Valganciclovir Impurity 1 | 1 |
| 130929-57-6 | Entacapone | 2 |
| 130931-83-8 | (1S,4R)-2-Aza-bicyclo[2.2.1]hept-5-en-3-one | 1 |
| 130931-84-9 | Peramivir Impurity 14 (Hydrochloride) | 1 |
| 130974-86-6 | N-(Chlorophenyl)-N'-hydroxyguanidine | 1 |
| 130996-24-6 | Dehydro Lacidipine | 1 |
| 131023-37-5 | 2-Chloro-1-(2,7-dichloro-9H-fluoren-4-yl)-ethanone (LF-2) | 1 |
| 131023-43-3 | 2-(9H-Carbazol-1-yl)acetic acid | 1 |
| 131023-44-4 | 8-Chlorocarbazole-1-acetic Acid | 1 |
| 131028-54-1 | {4-[2-(Dimethylamino)ethoxy]phenyl}methanol | 1 |
| 131064-74-9 | 2-((R)-3-(((S)-1-Ethoxy-1-oxo-4-phenylbutan-2-yl)amino)-2-oxo-2,3,4,5-tetrahydro-1H-benzo[b]azepin-1-yl)acetic Acid | 1 |
| 131064-75-0 | Benazepril EP Impurity A | 1 |
| 131083-16-4 | Pyrromethene 567 | 1 |
| 131086-22-1 | Lamivudine EP Impurity B | 1 |
| 131086-26-5 | Lamivudine Uracil Derivative | 1 |
| 131100-00-0 | (R)-4-Bromo-1-((3aS,4S,6S,7aR)-3a,5,5-trimethylhexahydro-4,6-methanobenzo[d][1,3,2]dioxaborol-2-yl)butan-1-amine hydrochloride | 1 |